Genomics, Proteomics and Biotechnology
The Establishment of integrated informative and analytical platform to conduct biomedical research at KFU, search and validation new of biomarkers, study human pathogenesis at the molecular level. Training and education of specialists, who will be able to conduct research with omics technologies and successfully integrate data to achieve competitive advantages, create new academic programs in system biology and medicine.
Development of new approaches to molecular diagnostics and treatment of oncological diseases.
Microbial Biotechnologies OpenLab
Development of new approaches to understand the molecular mechanisms and genetic factors responsible for antibiotic resistance in bacteria, in particular, the contribution of efflux systems. Understanding molecular mechanisms responsible for in traspecific variation in telomere length, development of efficient technologies for their creation of transgenic plants to improve growth and cropping capacity, investigation of plant metabolism.
Protein and Cell Interrelations OpenLab
Apoptosis and autophagy of blood cells in autoimmune diseases; interaction of antinuclear antibodies with nuclear proteins and DNA at molecular; level; structural foundations of biologically active peptides and low molecular weight proteins; molecular and cell mechanisms of blood clot retraction in norm and in pathology.
Development of new approaches to research of nanomaterials toxicity; fabrication of functional nanocontainers based on halloysite nanotubes for targeted delivery of biologically active compounds into cells; development of composite biopolymer matrixes modified by halloysite nanotubes for tissue engineering; cell surface engineering, fabrication of magnetic-modified carriers.
